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than in men (10 vs 26%) (<0.001). The frequency of non specific VT (ventric-
ular flutter or fibrillation) was similar in women and men (16 vs 19%). The
frequency of negative EPS was higher in women than in men (73 vs 55%)
(p<0.001). Syncope was related to hypervagotonia more frequently in women
than in men (15 vs 7%) (p<0.01). Other causes of syncope were similar in
women and men as supraventricular tachycardia (13 vs 14.5%) (NS), AV con-
duction disturbance (9 vs 8%) (NS), coronary ischemia (9 vs 8%) (NS). Non-
invasive and invasive studies remained more frequently negative in women
(27%) than in men (16%) (p<0.01). Implantable defibrillator (ICD) was
implanted less frequently in women than in men (6 vs 14%) (p< 0.04). The
frequency of sudden death (6 vs 5%) and heart failure-related death (9 vs
12%) or heart failure-related death and heart transplantation (10.5 vs 15%)
were similar.
Conclusions: Women with heart disease and syncope had less inducible
monomorphic VT than men, had more hypervagotonia and unexplained syn-
cope than men. However, despite a similar LVEF, their prognosis was similar.
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Purpose and methods: AVR by bioprothesis was performed in 268 con-
secutive patients (mean age 75±8 years) not paced previously. Incidence of
AVB was assessed during post-operative phase and follow-up (F.up). Multi-
variable analysis was performed to assess predictive factors of AVB.
Results: during post-operative phase AVB occured in 19 pts (7.1%) and
persisted in 12 patients (4.5%) requiring pacemaker (PM) implantation.
During F.up (mean 29 months) AV block requiring PM implantation occured
in 6 patients (2.3%) with a mean delay of 10 months.
In multivariable analysis predictive factors of early AVB were: previous
right bundle branch block (p=0.04), and extra corporeal circulation (ECC)
time (p=0.04). During F.up predictive factors were pre-operative bundle
branch block (p=0.04) and regressive post-operative AVB (p=0.007) Among
7 patients with regressive early AVB, 3 patients experienced recurrent AVB:
all have pre-operative bundle branch block; no recurence was observed in the
4 other patients with sharp QRS.
Conclusions: In this series early AVB after AVR occured in 7.1% of
patients and required PM implantation in 4.5%. During F.up AVB occured in
6 patients. Predictive factors of AVB were previous right bundle branch block
and ECC time for early AVB, previous bundle branch block and regressive
early AVB for late AVB. All patients with regressive early AVB and previous
bundle branch block have recurence of AVB in F.up and should be considered
for early PM implantation.
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Introduction: Familial amyloid polyneuropathy (FAP) is an autosomic
dominant disease induced by the mis-folding of a mutated precursor of
Albumin (transthyretin). Cardiopathy due to FAP include myocardial infiltra-
tion and conduction disturbances.
The Val30Met mutation is the most common. The aim of our study was to
compare electrophysiological characteristics of the Val30Met population to
other FAP population.
Methods & Results: Data from 121 patients with genetically proven FAP
were analysed. Standard ECG, echocardiography and electrophysiological
study were performed. Surface ECG was abnormal in 47% (NS). Main results
are shown in the following table:
Conclusion: Electrophysiological parameters differed significantly in car-
diac amyloidosis due to FAP according to the genotype. Amongst patients car-
rying other mutation than Val30Met, cardiac infiltration and infra nodal block
were more common and seemed to be related.
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In cardiac resynchronization therapy (CRT) procedure, left ventricular lead
(LV) implantation is time-consuming. In this clinical setting, no study has
investigated the impact of right atrium anatomical parameters on both CRT
implantation procedure duration and X-ray exposure. Additionally, only few
studies have examined the coronary sinus (CS) using dual source 64-Multi
Slice Computed Tomography (DS 64-MSCT), and its impact on CRT proce-
dure parameters has not yet been investigated.
The aim of this prospective study was to identify local anatomical predic-
tive factors of difficult CRT implantation procedure using DS 64-MSCT.
Between January and July 2010, 50 consecutive patients underwent primo
CRT implantation. The patient population had a mean age of 70±10 years with
NYHA Class 3.2±0.3 heart failure, LVEF 30±4%, and QRS width
157±30 ms. CRT implantation was attempted in 50 patients, and first LV lead
implantation was obtained in 49/50 patients (98%).One implantation (2%)
failed due to unsuccessful LV lead implant. Procedure parameters were as fol-
lows:median procedure time (skin to skin), 51 min (38 min); median fluoros-
copy procedure time, 11.9 min (22 min); median LV fluoroscopic time, 10.3
min (22 min). In 10 patients (20%), procedures were difficult requiring an
implantation lasting 85 min. The only predictive factor for difficult CRT
implantation was the insertion level of the CS ostium (CSO), evaluated by the
distance between the CSO and the bottom floor of the right atrium.
Conclusions: Today, despite improvements in the materials used problems
still remain in CRT procedure. In this clinical setting, the only predictive
factor for very long CRT procedures is the CSO level insertion (located
high).This anatomical anomaly is responsible for 20% of difficult CRT device
implantation procedures. Taking this anatomical parameter into account as
evaluated by DS 64-MSCT prior to surgery may help operators reduce both
operating and fluoroscopy times.
Val30Met other mutations P
n 87 34
age 42±13 54±8 <0.0001
IVS (mm) 11±3 13±3 <0.0001
AH interval (ms) 113±38 94±17 0.007
Wenckebach point (bpm) 126126±32 154±23 <0.0001
HV interval (ms) 60±12 68±16 0.004
HV interval was 70 ms in 39% of the patients. In patients carrying other 
mutations than Val30Met, cardiac infiltration assessed by IVS thickness was 
correlated with a longer HV interval (R=0.63, P=0.0003). Such association 
wasn't found considering Val30Met patients.
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Introduction: Patients with very dilated left ventricle are less responder to
CRT. We evaluate implant process and per-operative impact of adding a
second LV lead in this population.
Methods: We consider 15 patients with CRT-D indication and EDLVD
70 mm.
Additional time for 2nd LV lead was limited to 40 minutes. Per-operative
impact was evaluated using an external hemodynamic sensor influenced by
cardiac contractility (PEA sensor). LV 1 is the postero-lateral one, the LV2 is
the high lateral or diagonal one. All patients with successful implantation were
discharged in Triv pacing mode.
We evaluate the best configuration (regarding contractility) for each LV
lead (BIV or LV only pacing mode). Comparing both configurations we
define the optimal lead, and the non-optimal one.
We compare these two configurations with the best configuration using the
two left ventricular lead (Triv pacing or dual left pacing) called the “optimal
dual left configuration”.
Results: 13 pts were successfully implanted with 2 LV leads (mean addi-
tional time=25 mins. [9-40]).
For 7 cases the optimal left lead is the postero-lateral one, for 6 it was the
high lateral or diagonal.
The “Optimal dual left configuration” upgrades the hemodynamic value
for more than 40% (41% [–2; 115]) compared with the non optimal lead,
and up to 10% (12% [–9,39; 41,82]) compared with the optimal one. 7/13 patients
have more than 10% of increase compared with optimal LV lead and the
positive impact of using the two LV lead is confirmed (TRIV vs Optimal
>0, p<0,05).
Choosing the optimal lead versus the non optimal one (40%) is statistically
superior than using the optimal dual left configuration versus the optimal lead
only (10%) (sign test p=0.0005).
Conclusions: In patients with dilated left ventricle, adding a second LV
lead ensures having the benefit of the best positioned left lead, and dual left
configuration adds an additional acute benefit over standard CRT.
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Guidelines recommend the electrophysiological evaluation of preexcitation
syndrome (PS) and report the indications of accessory pathway (AP) ablation
and the use of antiarrhythmic drugs for the treatment of supraventricular
tachycardias (SVT). PS-related adverse presentation defined as a documented
life-threatening haemodynamically not tolerated arrhythmia, should disappear.
The purpose of the study was to evaluate the prevalence of adverse events in
patients with known PS and their cause.
Methods: Adverse presentation occurred in 65 patients between 1990 and
2010 among 735 patients aged from 5 to 85 years (34.5±17), consecutively
recruited for a PS. Electrophysiological study (EPS) was systematic.
Results: The prevalence of adverse event was 8.5%. It was the first event
of the disease in 36 patients who had never ECG recording nor symptoms
before malignant arrhythmia (group I); 21 patients had symptoms of tachy-
cardia but no ECG was recorded and PS was unknown (group II). PS was
known but was not studied in 8 patients (group III): adverse event occurred
after heavy surgery (n=3), after use of calcium inhibitors (n=4) to treat spon-
taneous SVT and use of salbutamol (n=1). At EPS all group I and II patients
but 3, had the criteria of a malignant form of PS (maximal rate through
AP>240 bpm in control state, >300 bpm after isoproterenol in AF). In group
III, only 5 of 8 had the electrophysiological criteria of malignancy. Malignant
form at EPS was less frequent in group III than in group I and II (p<0.003).
Conclusions: EPS which should be systematic, because malignant form
was generally noted in asymptomatic or symptomatic patients with a PS who
presented a poorly-tolerated arrhythmia or a ventricular fibrillation. However
the risk can be underestimated in patients who will have a heavy surgery.
More, the management of PS remains to be improved, because some adverse
events are related to classically contraindicated drugs as calcium inhibitor
used to treat SVT.
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Introduction: Transvenous ventricular pacing (VP) has been traditionally
performed from the right ventricular apex (RVA) because convenience of
pacing electrode positioning and long-term pacing stability. Recently, the
adverse effects of pacing RVA have emerged. An increase in cumulative per-
centage of RVA pacing in patients treated with pacemakers results in
increased risk of heart failure hospitalization, and atrial fibrillation (AF).
To decrease the adverse consequences of RVA pacing, currently two strat-
egies are proposed: 1) substitute other VP sites, (right ventricular septum or
left ventricle), 2) use dual-chamber pacemakers with new function: Manage
Ventricular Pacing (MVP™) which operates in AAI/R mode with backup VP
during AV block (AVB).
Insertion level of the CS ostium (CSO)
